Qiagen N.V (QGEN) | Financial Analysis & Statements
Qiagen N.V. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
540.4M
Gross Profit
325.3M
60.19%
Operating Income
121.9M
22.55%
Net Income
107.8M
19.95%
EPS (Diluted)
$0.52
Balance Sheet Metrics
Total Assets
6.3B
Total Liabilities
2.5B
Shareholders Equity
3.8B
Debt to Equity
0.66
Cash Flow Metrics
Operating Cash Flow
134.3M
Free Cash Flow
116.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Qiagen N.V Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.1B | 2.0B | 2.0B | 2.1B | 2.3B |
| Cost of Goods Sold | 790.5M | 1.0B | 731.6M | 757.0M | 800.8M |
| Gross Profit | 1.3B | 967.4M | 1.2B | 1.4B | 1.5B |
| Gross Margin % | 62.2% | 48.9% | 62.8% | 64.7% | 64.4% |
| Operating Expenses | |||||
| Research & Development | 187.5M | 193.5M | 198.5M | 189.9M | 190.0M |
| Selling, General & Administrative | 583.7M | 564.4M | 579.2M | 603.9M | 584.5M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 771.2M | 757.9M | 777.7M | 793.8M | 774.4M |
| Operating Income | 520.3M | 199.9M | 445.2M | 576.2M | 657.8M |
| Operating Margin % | 24.9% | 10.1% | 22.7% | 26.9% | 29.2% |
| Non-Operating Items | |||||
| Interest Income | 64.3M | 68.0M | 79.0M | 32.8M | 9.6M |
| Interest Expense | 33.3M | 43.8M | 53.4M | 58.4M | 54.5M |
| Other Non-Operating Income | -61.1M | -102.9M | -41.0M | -38.0M | 12.9M |
| Pre-tax Income | 490.3M | 121.1M | 429.8M | 512.6M | 625.8M |
| Income Tax | 65.4M | 37.6M | 88.5M | 89.4M | 113.2M |
| Effective Tax Rate % | 13.3% | 31.0% | 20.6% | 17.4% | 18.1% |
| Net Income | 424.9M | 83.6M | 341.3M | 423.2M | 512.6M |
| Net Margin % | 20.3% | 4.2% | 17.4% | 19.8% | 22.8% |
| Key Metrics | |||||
| EBITDA | 771.7M | 470.4M | 723.9M | 824.1M | 923.0M |
| EPS (Basic) | $2.06 | $0.41 | $1.55 | $1.92 | $2.33 |
| EPS (Diluted) | $2.04 | $0.40 | $1.53 | $1.90 | $2.28 |
| Basic Shares Outstanding | 206074698 | 205309513 | 221301620 | 220749690 | 220261742 |
| Diluted Shares Outstanding | 206074698 | 205309513 | 221301620 | 220749690 | 220261742 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Qiagen N.V Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 839.0M | 663.6M | 668.1M | 730.7M | 880.5M |
| Short-term Investments | 259.9M | 489.4M | 389.7M | 687.6M | 184.8M |
| Accounts Receivable | 402.6M | 349.3M | 381.9M | 323.8M | 362.1M |
| Inventory | 301.9M | 279.3M | 398.4M | 358.0M | 327.5M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 2.0B | 2.0B | 2.1B | 2.4B | 2.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 153.1M | 0 | 0 | 0 | 0 |
| Goodwill | 5.8B | 5.2B | 5.5B | 5.2B | 5.3B |
| Intangible Assets | 386.4M | 303.8M | 526.8M | 544.8M | 627.4M |
| Long-term Investments | - | 3.2M | 3.1M | 131.4M | 190.4M |
| Other Non-Current Assets | 122.0M | 243.8M | 197.0M | 202.9M | 303.4M |
| Total Non-Current Assets | 4.3B | 3.7B | 4.0B | 3.9B | 4.0B |
| Total Assets | 6.3B | 5.7B | 6.1B | 6.3B | 6.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 72.7M | 83.3M | 84.2M | 98.7M | 101.2M |
| Short-term Debt | 28.8M | 77.8M | 610.2M | 411.8M | 869.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 94.2M | 113.2M | 118.0M | 192.2M | 257.6M |
| Total Current Liabilities | 512.1M | 543.6M | 1.1B | 974.5M | 1.5B |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.8B | 1.3B | 921.8M | 1.5B | 1.1B |
| Deferred Tax Liabilities | - | - | - | - | 37.6M |
| Other Non-Current Liabilities | 207.4M | 240.6M | 207.4M | 218.0M | 246.9M |
| Total Non-Current Liabilities | 2.0B | 1.6B | 1.2B | 1.8B | 1.5B |
| Total Liabilities | 2.5B | 2.1B | 2.3B | 2.8B | 3.1B |
| Equity | |||||
| Common Stock | 2.5M | 2.6M | 2.7M | 2.7M | 2.7M |
| Retained Earnings | 2.7B | 2.4B | 2.5B | 2.2B | 1.8B |
| Treasury Stock | 31.8M | 74.9M | 133.0M | 160.2M | 189.7M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.8B | 3.6B | 3.8B | 3.5B | 3.1B |
| Key Metrics | |||||
| Total Debt | 1.8B | 1.4B | 1.5B | 1.9B | 2.0B |
| Working Capital | 1.5B | 1.4B | 1.1B | 1.4B | 592.1M |
Balance Sheet Composition
Qiagen N.V Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 424.9M | 83.6M | 341.3M | 423.2M | 512.6M |
| Depreciation & Amortization | 193.7M | 203.3M | 205.3M | 208.4M | 214.9M |
| Stock-Based Compensation | 50.4M | 43.6M | 47.1M | 49.5M | 38.4M |
| Working Capital Changes | 5.3M | 129.9M | -135.8M | -73.0M | -72.2M |
| Operating Cash Flow | 670.7M | 464.1M | 506.5M | 654.9M | 726.3M |
| Investing Activities | |||||
| Capital Expenditures | -201.0M | -167.2M | -149.7M | -129.2M | -189.9M |
| Acquisitions | -291.2M | 0 | -149.5M | -63.7M | 0 |
| Investment Purchases | -371.8M | -688.4M | -979.3M | -1.4B | -400.3M |
| Investment Sales | 597.1M | 585.0M | 1.3B | 883.1M | 359.6M |
| Investing Cash Flow | -299.2M | -245.2M | -74.6M | -706.7M | -185.8M |
| Financing Activities | |||||
| Share Repurchases | - | -292.1M | 0 | 0 | -100.0M |
| Dividends Paid | -54.2M | - | - | - | - |
| Debt Issuance | 742.3M | 494.2M | 0 | 371.5M | 0 |
| Debt Repayment | -534.2M | -601.5M | -436.8M | -480.0M | -41.3M |
| Financing Cash Flow | -179.0M | -422.9M | -470.6M | -125.8M | -150.4M |
| Free Cash Flow | 447.2M | 502.3M | 296.7M | 565.9M | 432.5M |
| Net Change in Cash | 192.5M | -203.9M | -38.7M | -177.6M | 390.1M |
Cash Flow Trend
Qiagen N.V Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
18.76
Forward P/E
13.90
Price to Book
2.09
Price to Sales
3.77
PEG Ratio
0.87
Profitability Ratios
Profit Margin
20.33%
Operating Margin
27.42%
Return on Equity
11.57%
Return on Assets
5.77%
Financial Health
Current Ratio
3.90
Debt to Equity
48.56
Beta
0.79
Per Share Data
EPS (TTM)
$2.04
Book Value per Share
$18.33
Revenue per Share
$10.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| QGEN | 7.9B | 18.76 | 2.09 | 11.57% | 20.33% | 48.56 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Revvity | 9.7B | 45.77 | 1.46 | 3.22% | 8.45% | 46.87 |
| Icon plc | 9.0B | 15.52 | 0.94 | 6.27% | 7.40% | 38.26 |
| Charles River | 8.3B | 681.33 | 2.61 | -4.23% | -3.60% | 81.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.





